Gayle Bresnahan

Gayle Bresnahan is currently the Director of Clinical Operations at Angiocrine Bioscience. Gayle has over 15 years of experience in the clinical research field. Gayle began their career as a Clinical Project Associate at Vical in 2000 and has since held positions of increasing responsibility at Gen Probe, Dexcom, Phenomix Corporation, Ambit Biosciences Corporation, Halozyme Therapeutics, Inc., Intercept Pharmaceuticals, and Travere Therapeutics (formerly Retrophin).

Gayle has overseen the management of several Phase 3 global clinical trials during their career. Gayle is experienced in managing clinical trials in a variety of therapeutic areas, including but not limited to: cardiovascular disease, diabetes, oncology, and rare disease.

Gayle earned their Bachelor’s degree in Biology from the University of California, San Diego.

Gayle Bresnahan has a certification from Emtrain in preventing workplace harassment.

Their manager is Shawn Sheeron, VP, Clinical Operations.